OBJECTIVES The aim of this study was to investigate the correlation between in-stent neointimal tissue without features of neoatherosclerosis and long-term clinical outcomes.
P athological studies have demonstrated that neointima within a stent comprises various tissue components including collagen, proteoglycan, smooth muscle, fibrin, and thrombus (1-3).
However, previous imaging modalities, such as angiography and intravascular ultrasound, have a limited ability to assess the neointimal characteristics due to low resolution. Intravascular optical coherence tomography (OCT) has higher resolution and is useful for the qualitative as well as quantitative evaluation of neointimal tissue (4, 5) . Recent OCT studies have reported differential morphological characteristics of neointimal tissue, which correlated well with histological findings (4, 6, 7) . Furthermore, the atherosclerotic change (neoatherosclerosis) of neointimal tissue inside a stent is now thought to be an underlying mechanism of late stent failure (8, 9) . However, the relationship between different OCT-based neointimal tissue without features of neoatherosclerosis and long-term clinical outcomes has not been investigated. Therefore, the aim of this study was to investigate the correlation between in-stent neointimal characteristics without features of neoatherosclerosis as assessed by OCT and long-term clinical outcomes. and biolimus-(Nobori) eluting stents. DES implantation was performed using conventional techniques.
Unfractionated heparin was administered as an initial bolus of 100 IU/kg, with additional boluses administered during the procedure to achieve an activated clotting time of 250 to 300 s. Dual antiplatelet therapy (aspirin and clopidogrel) was recommended to all patients for at least 12 months after DES implantation.
General inclusion and exclusion criteria of follow-up OCT procedures were previously reported (10) . At the time of OCT follow-up, the clinical presentation of the patients was as follows: 7 patients had acute coronary syndrome, 25 patients had stable angina, and 304 patients were asymptomatic. The reasons for follow-up angiography were: 1) evidence of myocardial ischemia by stress test or clinical presentation of coronary artery disease (n ¼ 32, 9.5%); or 2) planned routine follow-up angiography (n ¼ 304,
90.5%).
A major adverse cardiac event (MACE) was defined as cardiovascular death, nonfatal myocardial infarction, and target-lesion revascularization. Clinical events were defined according to the Academic Research Consortium (11) . All deaths were considered cardiovascular deaths unless a definite noncardiovascular cause was established. Myocardial infarction was defined as the presence of clinical symptoms, electrocardiographic changes, or abnormal imaging findings of myocardial infarction combined with an increase in creatine kinasemyocardial band fraction >3 times the upper limit of the normal range or an increase in troponin T/troponin I to more than the 99th percentile of the upper limit of normal, all of which were unrelated to an interventional procedure (11, 12) . Stent thrombosis was defined according to the recommendations of the Academic Research Consortium (11, 13) . Target Homogeneous type (A), heterogeneous type (B), layered type (C).
OCT-Based Neointima 2.9% in the homogeneous group vs. 7.3% in the layered group, p ¼ 0.001 (Table 3, Fig. 2) . In 3 patients with neoatherosclerosis who were excluded from this study, MACE did not occur during a median of 
